In the past years, genome wide association studies (GWAS) have provided evidence that inter-individual susceptibility to diverse pathological conditions can reveal a common genetic architecture. Through the analysis of congenital heart disease (CHD) and neuroblastoma (NB) GWAS data, we aimed to dissect the genetic susceptibility shared between these conditions, which are known to arise from neural crest cell (NCC) migration or development abnormalities, via identification and functional characterization of common regions of association. Two loci (2q35 and 3q25.32) harbor single nucleotide polymorphisms (SNPs) that are associated at a p-value < 10 −3 with conotruncal malformations and ventricular septal defect respectively, as well as with NB. In addition, the lead SNP in 4p16.2 for atrial septal defect and the lead SNP in 3q25.32 for tetralogy of Fallot are less than 250 Kb distant from the lead SNPs for NB at the same genomic regions. Some of these shared susceptibility loci regulate the expression of relevant genes involved in NCC formation and developmental processes (such as BARD1, MSX1, and SHOX2) and are enriched in several epigenetic markers from NB and fetal heart cell lines. Although the clinical correlation between NB and CHD is unclear, our exploration of a possible common genetic basis between NB and a subset of cardiac malformations can help shed light on their shared embryological origin and pathogenetic mechanisms.
CHD Genotypes
Genotypes from 5159 controls and patients with seven different subtypes of CHD, namely atrial septal defect/patent foramen ovale (ASD/PFO, 340 cases), conotruncal malformations (CM, 151 cases), double outlet right ventricle (DORV, 96 cases), left-sided malformations (LH, 387 cases), transposition of the great arteries (TGA, 207 cases), tetralogy of Fallot (ToF, 835 cases), and ventricular septal defect (VSD, 191 cases), were those included in the work of Cordell and colleagues [9] . Manhattan plots of the CHD GWAS are available in Figure S1 .
CHD Genotypes Imputation
We used the Michigan Imputation Server [28] to perform imputation on the CHD datasets (reference panel: 1000G Phase 3 v5).
CHD Association Analysis
Dosage vcf files from the imputation output were fed to SNPTEST v2.5.4 beta1 [29] software and frequentist association test was used to compute summary statistics.
Evaluation of the Extent of Shared Genetics
The first step of our workflow (Figure 1 ) was the evaluation of the genome-wide shared genetics between NB and CHD. To this end, we pruned the whole set of common SNPs based on linkage disequilibrium (LD) with plink v1.9 [30] using a r 2 threshold of 0.2 (plink -indep-pairwise function; parameters used are: r 2 = 0.2; window size = 500 Kb; step size = 20) in order to consider only SNPs in approximate linkage equilibrium and evaluated the number of independent SNPs with association p-values above and below several thresholds (0.05, 0.01, 0.005, 0.001, 0.0005, 0.0001) in NB and in each CHD condition. This procedure prevents the overestimation of association signals due to LD structure (such as when multiple signals are present from high LD regions). If the two conditions do not share a genetic basis, these values should not deviate from random expectation. A 2 × 2 table for each p-value cutoff was created and one-sided Fisher exact tests were used as the statistical measure of significance and strength of association. We also ran simulations to assess the validity of our results: For each CHD condition, each SNP was randomly assigned a p-value from the list of observed p-values deriving from the association analysis for that condition. We repeated this a thousand times, and an empirical p-value was calculated from the proportion of simulations having a number of SNPs below a given p-value threshold in both datasets (NB and one CHD type) greater than or equal to the observed number of SNPs below the same p-value threshold in both real datasets (NB and one CHD type) under consideration.
observed number of SNPs below the same p-value threshold in both real datasets (NB and one CHD type) under consideration. 
Identification of Colocalizing Association Signals
To identify shared association signals between NB and CHD, SNPs with an association p-value < 10 −3 [31] in both NB and at least one CHD dataset were selected, and shared association signals were defined as those regions containing at least 10 such SNPs within a distance of less than 100 Kb.
To identify possibly colocalizing but distinct association signals, we selected SNPs with an association p-value <10 −5 in NB or at least one CHD dataset, and candidate regions were identified if at least 10 SNPs within a distance of less than 100 Kb were present. The threshold of p-value < 10 −5 was chosen as it corresponds to an average of 1 false-positive association per GWAS in European populations [32] . The distance between lead SNPs of these candidate regions in NB and in the CHD conditions was then used to evaluate these potential colocalization signals deriving from distinct variants.
We also ran simulations to assess the significance of these distinct, colocalizing signals by randomly reshuffling the location of the associated regions in our NB dataset while keeping their size fixed: An empirical p-value was calculated from the proportion of simulations having a number of regions less than 250 Kb distant between NB and CHD greater than or equal to the real datasets.
A method proposed by Pickrell and colleagues [33] was also used to detect colocalizing regions. The algorithm generates posterior probabilities through a Bayesian approach for the hypotheses that 
To identify possibly colocalizing but distinct association signals, we selected SNPs with an association p-value < 10 −5 in NB or at least one CHD dataset, and candidate regions were identified if at least 10 SNPs within a distance of less than 100 Kb were present. The threshold of p-value < 10 −5 was chosen as it corresponds to an average of 1 false-positive association per GWAS in European populations [32] . The distance between lead SNPs of these candidate regions in NB and in the CHD conditions was then used to evaluate these potential colocalization signals deriving from distinct variants.
A method proposed by Pickrell and colleagues [33] was also used to detect colocalizing regions. The algorithm generates posterior probabilities through a Bayesian approach for the hypotheses that the region harbors one variant associated to both, to only one or to none of the traits, or that the region contains one variant associated only to one trait and another variant associated only to the other trait.
Enrichment of Epigenetic Signatures in Susceptibility Loci
Enrichment in epigenetic features of several cell types related to neural crest cells (NCC) and heart, and NCC derived tumors (NB and melanoma) was computed through R VSE package from CRAN [34] . Briefly, it creates a network from SNPs that accounts for LD structure and generates a null model by sampling SNPs from a comprehensive pool of tag SNPs, thus recreating the same LD clusters as in the real data, matching each associated variant set to a random variant set with the same characteristics. Haploreg [35] was also used to perform enhancer enrichment analysis on sets of variants (binomial test), using as background frequency the overlap from 1000 Genome variants with a frequency above 5% in any population.
eQTL Analysis
LinDA [36] was used to identify genes regulated by variants of interest, as well as tissues involved. This tool takes as input a list of variants and queries 199 datasets belonging to 53 projects, comprising 15 human populations and 33 body districts, resulting in 486,244 eQTLs and 36,768 eGenes.
Results

Evaluation of the Genome Wide Extent of Shared Genetic Association
To evaluate the genome-wide shared genetic signals between NB and CHD, we selected a subset of independent SNPs in approximate linkage equilibrium with each other and evaluated for each condition the number of SNPs with association p-value above and below different thresholds. We used Fisher exact test and simulation analysis to evaluate whether NB and each CHD condition in turn share more SNPs above and below the p-value thresholds than expected by chance [37] (see Materials and Methods Section 2.5). We found some evidence of shared association signals between NB and ASD/PFO, between NB and CM, and between NB and VSD (Table 2, Figure 2 , Tables S2 and S3 ). As reported in Table 2 , SNPs with p-value less than 0.01 are shared more frequently than expected between NB and all CHD datasets (Fisher exact test p-value = 0.02). Common association signals are also observed for low p-value thresholds when considering NB and CM (<0.005; Fisher exact p-value = 0.04) and when considering NB and VSD (<0.0005; Fisher exact p-value = 0.05) and for high p-value thresholds when considering NB and ASD/PFO (<0.05; Fisher exact p-value = 0.02). The union of all CHD datasets is considered as well as the most significant subtypes from this analysis. After extracting SNPs in approximate linkage equilibrium (r 2 < 0.2) from the full set of all common SNPs (see Materials and Methods Section 2.5 for details), for p-values ranging from 0.0001 to 0.05, Fisher exact test was performed for the SNPs above and below p-value threshold in NB and in the given condition.
The union of all CHD datasets is considered as well as the most significant subtypes from this analysis. After extracting SNPs in approximate linkage equilibrium (r 2 < 0.2) from the full set of all common SNPs (see Materials and Methods Section 2.5 for details), for p-values ranging from 0.0001 to 0.05, Fisher exact test was performed for the SNPs above and below p-value threshold in NB and in the given condition. 
Identification of Colocalizing Association Signals between NB and CHD
We defined shared association regions as genomic locations harboring at least 10 SNPs with association p-value < 10 −3 in NB and in at least one CHD subtype (see Materials and Methods Section 2.6). With this procedure, we identified two main regions spanning over several Kb: one shared 
We defined shared association regions as genomic locations harboring at least 10 SNPs with association p-value < 10 −3 in NB and in at least one CHD subtype (see Materials and Methods Section 2.6). With this procedure, we identified two main regions spanning over several Kb: one shared between NB and VSD (3q25.32; 399 SNPs, Figure 2A ) and another one shared between NB and CM (2q35; 28 SNPs, Figure 2B ). Two smaller regions were also identified: 12q21.31 has overlapping association signals in VSD, ASD/PFO, and NB and 14q24.3 has few SNPs which are significant both in NB and in ToF (Table 3 ). In this last case the direction of effect of the colocalizing SNPs in both datasets is the same, supporting a genuine shared allelic risk; whereas in the other cases the direction of effect is opposite, implying a shared genetic basis [38] .
Following recent works that have pointed out the importance of effects mediated by distinct genetic determinants located in the same genomic regions for informing the causal relationship between different traits [33, [39] [40] [41] , we also evaluated evidence of this kind of spurious colocalization between NB and each CHD subtype. On the basis of the physical distance of lead SNPs in significant loci of association in NB and CHD we identified two colocalizing susceptibility regions: one region encompassing band 3q25, colocalizing between NB and ToF ( Figure 2C and Table 4 ), and one further region in band 4p16.2 in NB and ASD/PFO ( Figure S2 and Table 4 , empirical p-values < 0.04 and <0.03, respectively). Table S4 reports all regions in the analyzed datasets with p-value < 10 −5 and their relative distance.
We also used a Bayesian method designed to test whether some genomic regions may harbor distinct variants associated to multiple traits [33] (see Materials and Methods Section 2.6). We found ten instances with a posterior probability >0.9 of containing distinct variants associated to NB and one or more CHD subsets ( Table 5 ). Interestingly some of these identified regions were also identified through the other approaches although in different CHD subtypes: 2q35 has overlapping association signals between NB and CM ( Figure 2B ) and shows evidence of colocalization of NB with DORV and ToF (Figure 2D ,F) and 3q25.32 has overlapping association signals between NB and VSD (Figure 2A ) and shows evidence of colocalization of NB with DORV and ToF (Figure 2C ,E). Region 4p16 contains both a signal of colocalization between NB and ASD/PFO (see above), as well as a signal of colocalization between NB and DORV. Two further colocalizing regions were identified: 6p22 (colocalizing NB with CM and NB with DORV) and 11p15 (colocalizing NB with DORV and NB with ToF) ( Table 5 and Figure S2 ).
Enrichment in Epigenetic Markers in Colocalizing Regions
Epigenetic features overlapping genetic polymorphisms can help predict in which cell tissue that variant is likely to act [42] . Therefore we evaluated enrichment of several epigenetic markers from cell lines and tissues related to neural crest cells, NB, and heart development (see Table S5 for the complete list) in the set of the most significant SNPs previously identified (i.e., SNPs with p-value < 10 −3 in NB and in at least one CHD subset in the regions reported in Table 3 ). In order to account for LD structure and prevent enrichment inflation in case of SNPs residing in high LD blocks, we used the Variant Set Enrichment (VSE) package from CRAN [34] . Results are shown in Figure 3 . It can be seen that few NB cell lines (NB69, LAN1, BE2C) are significantly enriched in these regions. Interestingly (Table S6) , it can be inferred that 2q35 is an epigenetic hotspot and has signatures from many cell lines whereas 3q25.32 has several epigenetic signatures from adrenal and fetal heart, which are also abundant in 2q35. The core 15-state model source for epigenomes in HaploReg [35] also gives evidence of enrichment in fetal heart signatures (p-value = 0.024) in these cross-associated variants.
Annotation of Colocalizing Regions
We used the genetic variants from the shared (association p-value < 10 −3 ) and distinct (association p-value < 10 −5 ) colocalizing signals and queried them for eQTL annotation through LinDA (http: //linda.irgb.cnr.it/). Genes, variants, and tissues are listed in Table 6 and Table S7 . This procedure allows to annotate genes from multiple catalogs that are likely regulated by the list of variants given as input in a tissue specific manner. For each region is reported the number of SNPs that have an association p-value below 10 −3 in both datasets in that genomic region and the direction of effect, the genomic band, the left and right margins of this region, and its range in bases, and the lead SNPs in NB and in the CHD subtype with association p-values. The table shows only cases in which a lead SNP in a susceptibility locus of NB is less than 250,000 bp away from a lead SNP in a susceptibility locus of at least one CHD subtype. Figure 3 . Box plots represent the distribution of overlap of the epigenetic feature under consideration with random sets of markers matched to the real set in terms of numerosity and LD structure. The bar inside each box corresponds to the median enrichment score of the null set. Whiskers span from minimum value to first quartile and from third quartile to maximum value. Dots represent the estimated enrichment in the real set of SNPs considered. One feature still significant after stringent multiple testing correction (Bonferroni corrected p-value < 0.01) is marked in red.
We used the genetic variants from the shared (association p-value < 10 −3 ) and distinct (association p-value < 10 −5 ) colocalizing signals and queried them for eQTL annotation through LinDA (http://linda.irgb.cnr.it/). Genes, variants, and tissues are listed in Table 6 and Table S7 . This procedure allows to annotate genes from multiple catalogs that are likely regulated by the list of variants given as input in a tissue specific manner. Table 6 . eQTL mapping performed in shared and colocalizing susceptibility loci. Figure 3 . Box plots represent the distribution of overlap of the epigenetic feature under consideration with random sets of markers matched to the real set in terms of numerosity and LD structure. The bar inside each box corresponds to the median enrichment score of the null set. Whiskers span from minimum value to first quartile and from third quartile to maximum value. Dots represent the estimated enrichment in the real set of SNPs considered. One feature still significant after stringent multiple testing correction (Bonferroni corrected p-value < 0.01) is marked in red. Genes whose expression is affected by SNPs in identified susceptibility loci common to NB and CHD (see Results Section 3.4) are shown. Genomic bands and the number of variants analyzed affecting the expression of these genes is also reported.
Gene Band Number of SNPs
Discussion
The evaluation of shared association between epidemiologically linked conditions represents a powerful tool for the dissection of common and unique mechanisms in the development of phenotypic traits and the onset of pathological conditions [43, 44] . On the basis of possible co-occurrence of NB and CHD [18, 45] and their common derivation from NCC [21, 24] , we conducted a co-association study on these conditions, starting from a general evaluation of an excess of shared association signals, to a more detailed analysis of colocalizing association signals. We observed the strongest evidence of shared genetic architecture between NB and VSD, both at a genome-wide level ( Table 2 and Figure 2 ) and at single loci (Tables 3-5) , where in band 3q25.32 a region of nearly half Mb harbors 399 SNPs with association p-value below 10 −3 in both conditions, which supports a genuine shared effect. This same region also shows evidence of shared association between NB and ToF and between NB and DORV.
Most of the SNPs that we identified in these loci of shared association show an opposite allelic effect. It was reported in the literature that for several conditions with a common pathological basis, shared genomic loci of association (such as the ones resulting from phenotype cross-trait analysis) show an opposite effect in several cases, possibly implying opposite functional changes in different cells/tissues affecting the same molecular trait or pathway [39] .
Some of the regions detected by our colocalization analysis include intriguing candidate genes for NB and CHD. MSX1 (4p16.2) is a homeobox gene involved in neural crest specification [46] that has been already identified as a CHD susceptibility gene [47] . Our results suggest that common variants can affect MSX1 expression and can also predispose to NB. The role of MSX1 in NB biology is also supported by a recent paper that demonstrates a signaling axis leading from PHOX2B via MSX1 to Delta-Notch and proneural gene expression in NB pathogenesis [48] . Recently, NB has been diagnosed in a child with Wolf-Hirschhorn syndrome, a congenital disorder with characteristic facial features caused by microdeletion of the short arm of chromosome 4 encoding the MSX1 gene [49] .
Another relevant gene is SHOX2 (3q25.32), a member of the homeobox family which is one of the major genes involved in the development of the sinoatrial node [50] ; its proper function is of crucial relevance for the origin of arrhythmogenic heart disease [51] . Moreover, SHOX2 is implicated in specifying neural systems involved in processing somatosensory information, as well as in face and body structure formation [52, 53] and has been reported as involved in Cornelia de Lange syndrome-a condition that implies heart defects [52, 54] . The relevance of this gene is supported from its association with eQTLs.
Our results and those from the literature show that the aforementioned genes are involved in developmental processes and that their abnormal functioning due to genetic alterations could predispose to the development of NB and CHD. eQTL analysis points out the relevance of loci associated at 3q25.32; in fact 3 genes (MLF1, RP11-538P18.2, and RSRC1) are associated with variants relevant in at least four conditions: NB, DORV, ToF, and VSD. MLF1 in particular has been recently described in NB [25] and seems to play an important role in tumorigenesis. MLF1 is highly expressed in heart and has been identified as a novel modulator of cardiomyocyte proliferation [55] . Interestingly, our eQTL analysis using data from left ventricle tissues demonstrates that predisposing NB and CHD variants can affect MLF1 expression.
We found that the known NB susceptibility gene BARD1 (2q35) [4, 56] lies in close proximity to a candidate susceptibility locus for CM; copy number alterations at the BARD1 locus have been previously associated to developmental delay, coarctation of aorta and ToF [57] , suggesting a role of BARD1 in early organogenesis and heart formation.
The identification of regions of shared susceptibility can help in assigning a hierarchy in the pathogenic mechanisms of related conditions, and functional and epigenetic characterization of common associated SNPs from different traits can contribute to single out loci belonging to shared and unique pathways. Our results suggest a possible common genetic basis between these two NCC originating conditions. However, larger sample sizes and further studies will be needed to validate our results and better elucidate the shared genetic risk factors between NB and CHD.
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